GMMG Multiple Myeloma Registry
Recruiting
Observational Study
Multiple Myeloma
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 18 and older
- Sex
- Any
- Study type
- Observational
- Participants needed
- 999 (estimated)
- Sponsor
- Prof. Dr. Hartmut Goldschmidt · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
The goal of this observational study is to collect long-term clinical follow-up data on patients with multiple myeloma who participated in a therapy study of the German-Speaking Myeloma Multicenter Group (GMMG). Target variables of interest are:
Overall survival, progression-free survival and follow-up time.
The relevant registry data will be provided and evaluated together with the therapy stud…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Previous participation in a a therapy study of the GMMG study group
Exclusion Criteria:
* patients with organ amyloidosis at time of diagnosis
Contacts